Suzuki et al., 2010 - Google Patents
FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusionSuzuki et al., 2010
View HTML- Document ID
- 12905768299368355431
- Author
- Suzuki N
- Aoki M
- Warita H
- Kato M
- Mizuno H
- Shimakura N
- Akiyama T
- Furuya H
- Hokonohara T
- Iwaki A
- Togashi S
- Konno H
- Itoyama Y
- Publication year
- Publication venue
- Journal of human genetics
External Links
Snippet
Mutations in the fused in sarcoma (FUS, also known as translated in liposarcoma) gene have been recently discovered to be associated with familial amyotrophic lateral sclerosis (FALS) in African, European and American populations. In a Japanese family with FALS, we …
- 230000035772 mutation 0 title abstract description 46
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Suzuki et al. | FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion | |
Dickey et al. | PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically | |
Duric et al. | A negative regulator of MAP kinase causes depressive behavior | |
Holland et al. | Higher rates of decline for women and apolipoprotein E ε4 carriers | |
Yamamoto et al. | Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway | |
Oh et al. | The role of BDNF in age-dependent changes of excitatory and inhibitory synaptic markers in the human prefrontal cortex | |
Jones et al. | Distinct DNA methylation patterns of cognitive impairment and trisomy 21 in Down syndrome | |
Giess et al. | Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene | |
Souchet et al. | Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models | |
Sukjamnong et al. | Prenatal exposure to bisphenol A alters the transcriptome-interactome profiles of genes associated with Alzheimer’s disease in the offspring hippocampus | |
Foti et al. | Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease | |
Zara et al. | Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract | |
Zhao et al. | Loss of function of CMPK2 causes mitochondria deficiency and brain calcification | |
O'donovan et al. | Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia | |
McGoldrick et al. | Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression | |
Higuchi et al. | Mutations in COA7 cause spinocerebellar ataxia with axonal neuropathy | |
Pierson et al. | Exome sequencing and SNP analysis detect novel compound heterozygosity in fatty acid hydroxylase-associated neurodegeneration | |
Bagit et al. | Exercise and estrogen: common pathways in Alzheimer’s disease pathology | |
Yabe et al. | Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome | |
Giannoccaro et al. | Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature | |
Shimizu et al. | Sporadic ALS with compound heterozygous mutations in the SQSTM1 gene | |
Edgar et al. | Resilient emotionality and molecular compensation in mice lacking the oligodendrocyte-specific gene Cnp1 | |
Chiang et al. | Novel TARDBP mutations in Nordic ALS patients | |
Bennouna‐Greene et al. | Hippocampal dysgenesis and variable neuropsychiatric phenotypes in patients with Bardet–Biedl syndrome underline complex CNS impact of primary cilia | |
Anttonen et al. | ZNHIT3 is defective in PEHO syndrome, a severe encephalopathy with cerebellar granule neuron loss |